Standardization of pleural effusion-based tumor mutation burden (TMB) estimation using capture-based targeted sequencing

BACKGROUND: Tumor mutation burden (TMB) has received considerable attention as a potential predictive biomarker for response to anticancer treatment with immune checkpoint inhibitors (ICIs), and has been increasingly incorporated into clinical practice. Currently, TMB is often determined with tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yongfeng, Shen, Lan, Ji, Wenxiang, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867960/
https://www.ncbi.nlm.nih.gov/pubmed/33569442
http://dx.doi.org/10.21037/atm-20-7702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867960/
https://www.ncbi.nlm.nih.gov/pubmed/33569442
http://dx.doi.org/10.21037/atm-20-7702

Ejemplares similares